Skip to main content
. 2016 Dec 9;6:38561. doi: 10.1038/srep38561

Table 2. Comparison of clinical characteristics between the cerebral microbleeds (+) group and (−) group.

Variable Cerebral microbleeds
− (n = 206) + (n = 73)
n (%) n (%)
Clinical characteristics
 Age (years) ± SD 69.5 ± 5.9 70.2 ± 6.5
 Age (range) 59–89 54–87
 Sex (Male) 140 (68) 49 (67)
 BMI (kg/m2) ± SD 22.5 ± 2.7 23.4 ± 3.6*
 Hypertension 102 (50) 43 (59)
 Hyperlipidemia 118 (57) 47 (64)
 Diabetes mellitus 27 (13) 8 (11)
 History of stroke 2 (1.0) 3 (4.1)
 History of cardiovascular disease 8 (3.9) 6 (8.2)
 Antiplatelet therapy 17 (8.3) 12 (16)
 Anticoagulant therapy 7 (3.4) 4 (5.5)
 Drinking 140 (68) 41 (56)
 Smoking 26 (13) 5 (6.8)
 Education ≤12 yearsa 108 (53) 42 (60)
 baPWV (m/s) ± SD 1728 ± 306.9 1760 ± 298.9
 hs-CRP ≥ 0.1 mg/dL 55 (27) 22 (30)
Dental check-up findings
 Number of remaining teeth ± SD 22.9 ± 7.2 22.3 ± 8.3
 Dental caries+ 60 (29) 26 (36)
 CPI ≥ code 3 50 (24) 27 (37)*
Laboratory evaluations
 APOE ε4 allele carrierb 46 (23) 12 (17)
Streptococcus mutans-isolated 192 (93) 69 (95)
cnm-positive S. mutans-isolated 37 (18) 54 (74)**
 Collagen binding activity ≥10% 28 (14) 43 (59)**
Brain MRI findings
Distribution of CMBs
 Deep (%) 44 (60)
 Lobar (%) 20 (27)
 Mixed (%) 9 (12)
 PVH ≥ grade 2 24 (12) 11 (15)
 DWMH ≥ grade 2 50 (24) 27 (37)*
Cognitive functional evaluations
 MMSE (score) ± SD 28.5 ± 2.2 27.9 ± 2.0*
Letter fluency tasks
 “Ta” (score) ± SD 8.5 ± 3.5 7.6 ± 2.9*
 “Ka” (score) ± SD 10.0 ± 3.5 9.2 ± 3.0

*T-tests p < 0.05 and Chi-square tests p < 0.05, **T-tests p < 0.01 and Chi-square tests p < 0.01.

aData are missing for education (n = 4). bData are missing for APOE genotype (n = 7).

BMI; Body mass index, CPI; Community Periodontal Index, CMBs; Cerebral microbleeds.

PVH; Periventricular Hyperintensity, DWMH; Deep White Matter Hyperintensity, MMSE; Mini-Mental State Examination.